TANG CAPITAL MANAGEMENT LLC
CIK 1232621
13F filing for Q2 2026・No. 1,540
- Holdings
- US$2.2B
- Quarter change
- +US$232.82M
- Entries
- 41
- Net bought (estimate)
- −US$23.31M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 4
- Sold out 15
- Cut 5
- Added 7
- Corporate actions 0
- Unchanged 24
Largest holdings
40 stocks worth US$2.19B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| AURINIA PHARMACEUTICALS INCCOM | Added | 13,044,106 | US$221.36M | 10.11% |
| SYRESPYRE THERAPEUTICS INCCOM NEW | Unchanged | 1,892,200 | US$167.99M | 7.67% |
| MIRUM PHARMACEUTICALS INCCOM | Unchanged | 1,236,027 | US$144.7M | 6.61% |
| KINIKSA PHARMACEUTICALS INTLORD SHS CL A | Unchanged | 2,259,889 | US$144.52M | 6.60% |
| CELCUITY INCCOM | Added | 1,314,594 | US$137.53M | 6.28% |
| CORTCORCEPT THERAPEUTICS INCCOM | Unchanged | 1,500,000 | US$130.43M | 5.95% |
| PTCTPTC THERAPEUTICS INCCOM | Unchanged | 1,500,000 | US$122.36M | 5.59% |
| LAKEFRONT BIOTHERAPEUTICS NVSPON ADR | Unchanged | 3,785,991 | US$113.5M | 5.18% |
| CAPRICOR THERAPEUTICS INCCOM NEW | Added | 4,099,900 | US$98.73M | 4.51% |
| TARSUS PHARMACEUTICALS INCCOM | Added | 1,568,266 | US$98.71M | 4.51% |
Sign in (free) to see its 40 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.